These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21109170)

  • 1. Global spread of New Delhi metallo-β-lactamase 1.
    Leverstein-Van Hall MA; Stuart JC; Voets GM; Versteeg D; Tersmette T; Fluit AC
    Lancet Infect Dis; 2010 Dec; 10(12):830-1. PubMed ID: 21109170
    [No Abstract]   [Full Text] [Related]  

  • 2. Global spread of New Delhi metallo-β-lactamase 1.
    Hammerum AM; Toleman MA; Hansen F; Kristensen B; Lester CH; Walsh TR; Fuursted K
    Lancet Infect Dis; 2010 Dec; 10(12):829-30. PubMed ID: 21109169
    [No Abstract]   [Full Text] [Related]  

  • 3. Global spread of New Delhi metallo-β-lactamase 1.
    Poirel L; Hombrouck-Alet C; Freneaux C; Bernabeu S; Nordmann P
    Lancet Infect Dis; 2010 Dec; 10(12):832. PubMed ID: 21109172
    [No Abstract]   [Full Text] [Related]  

  • 4. First case of New Delhi metallo-beta-lactamase 1-producing Escherichia coli infection in Japan.
    Chihara S; Okuzumi K; Yamamoto Y; Oikawa S; Hishinuma A
    Clin Infect Dis; 2011 Jan; 52(1):153-4. PubMed ID: 21148536
    [No Abstract]   [Full Text] [Related]  

  • 5. CTX-M-type beta-lactamases affect community Escherichia coli treatment, Greece.
    Pournaras S; Ikonomidis A; Sofianou D; Tsakris A; Maniatis AN
    Emerg Infect Dis; 2004 Jun; 10(6):1163-4. PubMed ID: 15224673
    [No Abstract]   [Full Text] [Related]  

  • 6. Global spread of New Delhi metallo-β-lactamase 1.
    Bogaerts P; Verroken A; Jans B; Denis O; Glupczynski Y
    Lancet Infect Dis; 2010 Dec; 10(12):831-2. PubMed ID: 21109171
    [No Abstract]   [Full Text] [Related]  

  • 7. New Delhi metallo-beta-lactamase from traveler returning to Canada.
    Peirano G; Ahmed-Bentley J; Woodford N; Pitout JD
    Emerg Infect Dis; 2011 Feb; 17(2):242-4. PubMed ID: 21291595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A first case of New Delhi metallo-β-lactamase-7 in an Escherichia coli ST648 isolate in Japan.
    Mizuno Y; Yamaguchi T; Matsumoto T
    J Infect Chemother; 2014 Dec; 20(12):814-6. PubMed ID: 25193039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global spread of New Delhi metallo-β-lactamase 1.
    Koh TH; Khoo CT; Wijaya L; Leong HN; Lo YL; Lim LC; Koh TY
    Lancet Infect Dis; 2010 Dec; 10(12):828. PubMed ID: 21109168
    [No Abstract]   [Full Text] [Related]  

  • 10. Emergence of the IMP-8 metallo-β-lactamase in the Escherichia coli ST131 clone in Taiwan.
    Yan JJ; Tsai LH; Wu JJ
    Int J Antimicrob Agents; 2012 Sep; 40(3):281-2. PubMed ID: 22789726
    [No Abstract]   [Full Text] [Related]  

  • 11. [Quality control of antimicrobial susceptibility testing by disk diffusion test].
    Ma Y; Li JY; Jin SH
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):355-6. PubMed ID: 15558846
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of phenotypic and genotypic detection of penicillin G resistance of Staphylococcus aureus isolated from bovine intramammary infection.
    Haveri M; Suominen S; Rantala L; Honkanen-Buzalski T; Pyörälä S
    Vet Microbiol; 2005 Mar; 106(1-2):97-102. PubMed ID: 15737478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbapenem resistance among Escherichia coli and Klebsiella pneumoniae in a tertiary care hospital in south India.
    Nagaraj S; Chandran SP; Shamanna P; Macaden R
    Indian J Med Microbiol; 2012; 30(1):93-5. PubMed ID: 22361769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of NDM-7 in Germany, a new variant of the New Delhi metallo-β-lactamase with increased carbapenemase activity.
    Göttig S; Hamprecht AG; Christ S; Kempf VA; Wichelhaus TA
    J Antimicrob Chemother; 2013 Aug; 68(8):1737-40. PubMed ID: 23557929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Metan G; Zarakolu P; Cakir B; Hascelik G; Uzun O
    Int J Antimicrob Agents; 2005 Sep; 26(3):254-7. PubMed ID: 16122910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global spread of New Delhi metallo-β-lactamase 1.
    Göttig S; Pfeifer Y; Wichelhaus TA; Zacharowski K; Bingold T; Averhoff B; Brandt C; Kempf VA
    Lancet Infect Dis; 2010 Dec; 10(12):828-9. PubMed ID: 21109167
    [No Abstract]   [Full Text] [Related]  

  • 17. Are beta-lactams related to higher morbidity and mortality in urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli?
    You JH; Kei HW; Lau WC; Wong KY; Marasinghe T; Lee N; Ip M
    J Hosp Infect; 2008 Feb; 68(2):181-3. PubMed ID: 18194826
    [No Abstract]   [Full Text] [Related]  

  • 18. New Delhi metallo-beta-lactamase: a cautionary tale.
    Muir A; Weinbren MJ
    J Hosp Infect; 2010 Jul; 75(3):239-40. PubMed ID: 20435372
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York.
    Bratu S; Brooks S; Burney S; Kochar S; Gupta J; Landman D; Quale J
    Clin Infect Dis; 2007 Apr; 44(7):972-5. PubMed ID: 17342651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of carbapenems against a metallo-β-lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model.
    Souli M; Konstantinidou E; Tzepi I; Tsaganos T; Pefanis A; Chryssouli Z; Galani I; Giamarellos-Bourboulis E; Giamarellou H
    J Antimicrob Chemother; 2011 Mar; 66(3):611-7. PubMed ID: 21177674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.